• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

摩洛哥患者分离株中与利福平耐药相关的突变:系统评价

Mutations Associated with Rifampicin Resistance in Isolates from Moroccan Patients: Systematic Review.

作者信息

Eddabra Rkia, Neffa Mounsef

机构信息

Higher Institute of Nurses Professions and Health Techniques of Guelmim, Guelmim, Morocco.

Laboratory of Microbial Biotechnology and Plant Protection, Faculty of Sciences, University Ibn Zohr, Agadir, Morocco.

出版信息

Interdiscip Perspect Infect Dis. 2020 Oct 9;2020:5185896. doi: 10.1155/2020/5185896. eCollection 2020.

DOI:10.1155/2020/5185896
PMID:33133185
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7568785/
Abstract

BACKGROUND

In recent years, the treatment of tuberculosis has been threatened by the increasing number of patients with drug resistance, especially rifampicin resistance, which is the most effective first-line antibiotic against .

METHODS

We performed a systematic review of the literature by searching the PubMed database for studies of rifampicin-resistant (MTB) isolates from Moroccan patients, published between 2010 and 2020. The aim of this review was to quantify the frequency of the most common mutations associated with rifampicin resistance, to describe the frequency at which these mutations co-occur. Identified studies were critically appraised according to the Quality Assessment of Diagnostic Accuracy Studies-2 (QUADAS-2) tool.

RESULTS

6 studies met our inclusion criteria. Results show that 99.36% of MTB isolates had a single-point mutation, and the most commonly mutated codon of B gene is 531 with 70.33% of phenotypically resistant strains. However, 10.38% of MTB strains phenotypically resistant to RIF did not exhibit any mutation in the gene.

CONCLUSION

Identification of a resistance-associated mutation to rifampicin can be a good marker of drug-resistant TB, but lack of a mutation in the target sequence must be interpreted with caution.

摘要

背景

近年来,结核病的治疗受到耐药患者数量增加的威胁,尤其是对利福平耐药,利福平是对抗……最有效的一线抗生素。

方法

我们通过在PubMed数据库中搜索2010年至2020年间发表的关于摩洛哥患者耐利福平结核分枝杆菌(MTB)分离株的研究,对文献进行了系统综述。本综述的目的是量化与利福平耐药相关的最常见突变的频率,描述这些突变同时出现的频率。根据诊断准确性研究质量评估-2(QUADAS-2)工具对纳入的研究进行严格评估。

结果

6项研究符合我们的纳入标准。结果显示,99.36%的MTB分离株有单点突变,B基因最常发生突变的密码子是531,70.33%的表型耐药菌株为此突变。然而,10.38%表型对利福平耐药的MTB菌株在该基因中未表现出任何突变。

结论

鉴定利福平耐药相关突变可作为耐药结核病的良好标志物,但目标序列中缺乏突变必须谨慎解读。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/185f/7568785/42d89e703c30/IPID2020-5185896.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/185f/7568785/42d89e703c30/IPID2020-5185896.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/185f/7568785/42d89e703c30/IPID2020-5185896.001.jpg

相似文献

1
Mutations Associated with Rifampicin Resistance in Isolates from Moroccan Patients: Systematic Review.摩洛哥患者分离株中与利福平耐药相关的突变:系统评价
Interdiscip Perspect Infect Dis. 2020 Oct 9;2020:5185896. doi: 10.1155/2020/5185896. eCollection 2020.
2
Rifampicin resistance mutations in the 81 bp RRDR of rpoB gene in Mycobacterium tuberculosis clinical isolates using Xpert® MTB/RIF in Kampala, Uganda: a retrospective study.使用 Xpert® MTB/RIF 在乌干达坎帕拉检测结核分枝杆菌临床分离株中 rpoB 基因 81bpRRDR 区的利福平耐药突变:一项回顾性研究。
BMC Infect Dis. 2014 Sep 4;14:481. doi: 10.1186/1471-2334-14-481.
3
Rifampicin resistance mutations in the 81 bp RRDR of rpoB gene in Mycobacterium tuberculosis clinical isolates using Xpert MTB/RIF in Khyber Pakhtunkhwa, Pakistan: a retrospective study.在巴基斯坦开伯尔-普赫图赫瓦省使用Xpert MTB/RIF检测结核分枝杆菌临床分离株rpoB基因81bp利福平耐药决定区的利福平耐药突变:一项回顾性研究
BMC Infect Dis. 2016 Aug 12;16:413. doi: 10.1186/s12879-016-1745-2.
4
Profiling and identification of novel rpoB mutations in rifampicin-resistant Mycobacterium tuberculosis clinical isolates from Pakistan.巴基斯坦利福平耐药结核分枝杆菌临床分离株中新的 rpoB 突变的分析和鉴定。
J Infect Chemother. 2021 Nov;27(11):1578-1583. doi: 10.1016/j.jiac.2021.06.020. Epub 2021 Jul 7.
5
Reevaluating Rifampicin Breakpoint Concentrations for Mycobacterium tuberculosis Isolates with Disputed Mutations and Discordant Susceptibility Phenotypes.重新评估具有争议性突变和不一致药敏表型的结核分枝杆菌分离株的利福平断点浓度。
Microbiol Spectr. 2022 Feb 23;10(1):e0208721. doi: 10.1128/spectrum.02087-21. Epub 2022 Feb 2.
6
Occurrence of disputed rpoB mutations among Mycobacterium tuberculosis isolates phenotypically susceptible to rifampicin in a country with a low incidence of multidrug-resistant tuberculosis.在一个耐药结核病发病率较低的国家,表型上对利福平敏感的结核分枝杆菌分离株中出现有争议的 rpoB 突变。
BMC Infect Dis. 2019 Jan 3;19(1):3. doi: 10.1186/s12879-018-3638-z.
7
Utility of the REBA MTB-Rifa® assay for rapid detection of rifampicin resistant Mycobacterium tuberculosis.REBA MTB-Rifa®检测法在快速检测耐利福平结核分枝杆菌中的应用
BMC Infect Dis. 2013 Oct 15;13:478. doi: 10.1186/1471-2334-13-478.
8
Phenotypically occult multidrug-resistant Mycobacterium tuberculosis: dilemmas in diagnosis and treatment.表型隐匿的耐多药结核分枝杆菌:诊断与治疗中的困境
J Antimicrob Chemother. 2013 Dec;68(12):2915-20. doi: 10.1093/jac/dkt284. Epub 2013 Jul 9.
9
Mutation pattern in rifampicin resistance determining region of rpoB gene in multidrug-resistant Mycobacterium tuberculosis isolates from Pakistan.巴基斯坦耐多药结核分枝杆菌分离株中rpoB基因利福平耐药决定区的突变模式
Int J Mycobacteriol. 2014 Sep;3(3):173-7. doi: 10.1016/j.ijmyco.2014.06.004. Epub 2014 Jul 12.
10
Evaluation of rifampicin resistance and 81-bp rifampicin resistant determinant region of rpoB gene mutations of Mycobacterium tuberculosis detected with XpertMTB/Rif in Cross River State, Nigeria.在尼日利亚克罗斯河州,使用Xpert MTB/Rif检测结核分枝杆菌的利福平耐药性及rpoB基因突变的81bp利福平耐药决定区。
Int J Mycobacteriol. 2016 Dec;5 Suppl 1:S145-S146. doi: 10.1016/j.ijmyco.2016.09.007. Epub 2016 Oct 21.

引用本文的文献

1
Advancing against drug-resistant tuberculosis: an extensive review, novel strategies and patent landscape.对抗耐药结核病的进展:全面综述、新策略及专利态势
Naunyn Schmiedebergs Arch Pharmacol. 2025 Mar;398(3):2127-2150. doi: 10.1007/s00210-024-03466-0. Epub 2024 Oct 8.
2
Prevalence of Beijing Central Asian/Russian Cluster 94-32 among Multidrug-Resistant in Kazakhstan.哈萨克斯坦耐多药结核病患者中北京中亚/俄罗斯94-32簇的流行情况。
Antibiotics (Basel). 2023 Dec 20;13(1):9. doi: 10.3390/antibiotics13010009.
3
Effect of mixed Mycobacterium tuberculosis infection on rapid molecular diagnostics among patients starting MDR-TB treatment in Uganda.

本文引用的文献

1
Extract from used Xpert MTB/RIF Ultra cartridges is useful for accurate second-line drug-resistant tuberculosis diagnosis with minimal rpoB-amplicon cross-contamination risk.从使用过的 Xpert MTB/RIF Ultra 试剂盒中提取的样本可用于准确诊断二线耐药性结核病,且 rpoB 扩增子交叉污染风险最小。
Sci Rep. 2020 Feb 14;10(1):2633. doi: 10.1038/s41598-020-59164-3.
2
Classification of Mycobacterium tuberculosis DR, MDR,XDR Isolates and Identification of Signature MutationPattern of Drug Resistance.结核分枝杆菌耐多药、广泛耐药分离株的分类及耐药特征性突变模式的鉴定
Bioinformation. 2019 Apr 15;15(4):261-268. doi: 10.6026/97320630015261. eCollection 2019.
3
在乌干达,混合结核分枝杆菌感染对开始耐多药结核病治疗的患者快速分子诊断的影响。
BMC Infect Dis. 2024 Jan 10;24(1):70. doi: 10.1186/s12879-023-08968-5.
4
Effect of mixed Mycobacterium tuberculosis infection on rapid molecular diagnostics among patients starting MDR-TB treatment in Uganda.乌干达耐多药结核病治疗初治患者中混合结核分枝杆菌感染对快速分子诊断的影响。
Res Sq. 2023 Sep 28:rs.3.rs-3324330. doi: 10.21203/rs.3.rs-3324330/v1.
5
Isoniazid and Rifampicin Resistance-Conferring Mutations in Isolates from South Africa.来自南非的分离株中赋予异烟肼和利福平耐药性的突变
Pathogens. 2023 Aug 4;12(8):1015. doi: 10.3390/pathogens12081015.
6
Whole genome sequencing of drug resistance from extra-pulmonary sites.耐药性全基因组测序来自肺外部位。
Life Sci Alliance. 2023 Aug 17;6(11). doi: 10.26508/lsa.202302076. Print 2023 Nov.
7
Frequency of rpoB, katG, and inhA Gene Polymorphisms Associated with Multidrug-Resistant Complex Isolates among Ethiopian TB Patients: A Systematic Review.埃塞俄比亚结核病患者中与多重耐药复合分离株相关的rpoB、katG和inhA基因多态性频率:一项系统综述。
Interdiscip Perspect Infect Dis. 2022 Jun 16;2022:1967675. doi: 10.1155/2022/1967675. eCollection 2022.
8
Rifampicin Resistance Associated with Mutations in Neisseria gonorrhoeae Clinical Strains Isolated in Austria, 2016 to 2020.2016 年至 2020 年奥地利分离的淋病奈瑟菌临床株中与利福平耐药相关的突变。
Microbiol Spectr. 2022 Jun 29;10(3):e0275721. doi: 10.1128/spectrum.02757-21. Epub 2022 Jun 9.
9
Prevalence and Molecular Characteristics Based on Whole Genome Sequencing of Resistant to Four Anti-Tuberculosis Drugs from Southern Xinjiang, China.基于全基因组测序的中国新疆南部耐四种抗结核药物情况及分子特征分析
Infect Drug Resist. 2021 Aug 24;14:3379-3391. doi: 10.2147/IDR.S320024. eCollection 2021.
10
The Epistatic Landscape of Antibiotic Resistance of Different Clades of .不同进化枝抗生素抗性的上位性景观
Antibiotics (Basel). 2021 Jul 15;10(7):857. doi: 10.3390/antibiotics10070857.
Elucidation of drug resistance mutations in Mycobacterium tuberculosis isolates from North India by whole-genome sequencing.
通过全基因组测序阐明来自印度北部的结核分枝杆菌分离株的耐药突变。
J Glob Antimicrob Resist. 2020 Mar;20:11-15. doi: 10.1016/j.jgar.2019.05.019. Epub 2019 May 20.
4
Treatment outcomes of drug resistant tuberculosis patients in Morocco: multi-centric prospective study.摩洛哥耐药结核病患者的治疗结果:多中心前瞻性研究。
BMC Infect Dis. 2019 Apr 11;19(1):316. doi: 10.1186/s12879-019-3931-5.
5
The global tuberculosis epidemic: turning political will into concrete action.全球结核病流行:将政治意愿转化为具体行动。
J Thorac Dis. 2018 Sep;10(Suppl 26):S3149-S3152. doi: 10.21037/jtd.2018.08.73.
6
Rapid molecular assays for detection of tuberculosis.用于结核病检测的快速分子检测方法
Pneumonia (Nathan). 2018 May 25;10:4. doi: 10.1186/s41479-018-0049-2. eCollection 2018.
7
Mutations inside rifampicin-resistance determining region of rpoB gene associated with rifampicin-resistance in Mycobacterium tuberculosis.rpoB 基因内 rifampicin 耐药决定区的突变与结核分枝杆菌的 rifampicin 耐药相关。
J Infect Public Health. 2018 Sep-Oct;11(5):605-610. doi: 10.1016/j.jiph.2018.04.005. Epub 2018 Apr 26.
8
Diagnostic accuracy of GenoType MTBDR VER 2.0 in detecting second-line drug resistance to .GenoType MTBDR VER 2.0 检测二线药物耐药性的诊断准确性。
Int J Tuberc Lung Dis. 2018 Apr 1;22(4):419-424. doi: 10.5588/ijtld.17.0663.
9
Molecular characterization of mutations associated with resistance to second-line tuberculosis drug among multidrug-resistant tuberculosis patients from high prevalence tuberculosis city in Morocco.摩洛哥高结核负担城市耐多药结核病患者二线抗结核药物耐药相关突变的分子特征。
BMC Infect Dis. 2018 Feb 27;18(1):98. doi: 10.1186/s12879-018-3009-9.
10
Evolution of drug resistance in Mycobacterium tuberculosis: a review on the molecular determinants of resistance and implications for personalized care.结核分枝杆菌耐药性的演变:耐药分子决定因素及其对个体化治疗的影响综述。
J Antimicrob Chemother. 2018 May 1;73(5):1138-1151. doi: 10.1093/jac/dkx506.